Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
about
A kinesin-1 binding motif in vaccinia virus that is widespread throughout the human genomeVaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansReview: Capripoxvirus Diseases: Current Status and Opportunities for Control.A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.Repression of the A8L gene, encoding the early transcription factor 82-kilodalton subunit, inhibits morphogenesis of vaccinia virionsIdentification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans.F11-mediated inhibition of RhoA signalling enhances the spread of vaccinia virus in vitro and in vivo in an intranasal mouse model of infectionVaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusionVisualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions.Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain.Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivoCharacterization of vaccinia virus intracellular cores: implications for viral uncoating and core structureThe vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis.The vaccinia virus superoxide dismutase-like protein (A45R) is a virion component that is nonessential for virus replication.Vaccinia virus A21 virion membrane protein is required for cell entry and fusionGenetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8Interferon function is not required for recovery from a secondary poxvirus infection.Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.Therapeutic Vaccines and Antibodies for Treatment of Orthopoxvirus Infections.Smallpox vaccines: targets of protective immunity.Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge.Crystal structure of vaccinia viral A27 protein reveals a novel structure critical for its function and complex formation with A26 proteinAn epitope conserved in orthopoxvirus A13 envelope protein is the target of neutralizing and protective antibodiesT cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses.Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.Immunomodulator-based enhancement of anti smallpox immune responses.Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer.Isolation of a monoclonal antibody which blocks vaccinia virus infection.Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus.Characterization of ts 16, a temperature-sensitive mutant of vaccinia virusVaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.Vaccinia virus A17L open reading frame encodes an essential component of nascent viral membranes that is required to initiate morphogenesis.Development of a Genus-Specific Antigen Capture ELISA for Orthopoxviruses - Target Selection and Optimized ScreeningDistinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.The small GTP-binding protein rab6 functions in intra-Golgi transport.Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion proteinCytoplasmic ATR Activation Promotes Vaccinia Virus Genome ReplicationMolecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene.Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus.
P2860
Q24337857-D7DD7F7C-515E-4A32-BEE4-33A4EC0513E5Q27488704-34472CFE-C4EA-4A28-9E9C-23698F067FD5Q30252040-0FA38E74-6C62-454D-91F1-29C862FA7A5DQ30445071-B3A75C4F-B2CE-4F76-B66D-A4004FC6017BQ32157318-799BF748-F77A-4679-8E98-A780A7028CFFQ33271767-87E984BE-E2D0-453A-98A3-08188A50A10CQ33521248-2895FD1B-0FCE-414C-842B-02F834BC1F99Q33724218-F7A7B721-93FB-486D-A7E2-9B43D92D82F3Q33724230-EED767B7-C313-4168-BC73-FFBA244D63E0Q33785040-3AA5AAD8-2B0C-4576-9CD6-B85F2A911C1EQ33801656-D8C3E17E-92FA-4F6A-A020-619CF31FA1C9Q33802038-52F1F9BA-B1BD-4A71-932F-8A9C2C5249BDQ33811821-ACA3F0E2-9B07-439F-B8FB-A27CB5F4EEACQ33844429-27144306-0F24-4E16-BB8A-F0A5EC0766E3Q33908798-D1C24A81-8C2A-4B7F-BCD6-DAE6B92F18ADQ33932404-448B0673-84AF-4B7C-8C4D-652E7D80A687Q33943914-0A0CED05-9623-42BF-8516-5523DF60D916Q33987410-1F683A8A-7DF4-4CDF-B977-C502C2A9C546Q34447009-844BAD60-F834-4372-B71E-AD43578E2DC9Q34780607-AEF0A971-0F60-46BE-9D2E-CBB11898E315Q34910424-94083ED7-9158-4DE7-B547-7AB18CA028D0Q34976944-2A72D27C-EFB1-48FE-A412-AC46D39B3C2DQ35186318-1CBD4098-C183-468A-AD53-88B410B5DEC7Q35206861-D6879DA4-2D2A-4298-A122-21D212A269B2Q35234767-B44E84E2-AE9E-4C9C-9700-34B668EBFA4DQ35339702-3D3971E3-687A-4225-9EA2-49E6C728F2E8Q35391402-E433EEEA-AF3A-4CA6-8FC4-FC799F27F753Q35760869-AB719294-1309-44C6-87DC-134F3CF4529BQ35830307-462455BA-CEC8-40FF-84D4-10360EEE66C0Q35839800-602D17E9-C641-48A5-A039-E3290FF7618FQ35851038-B3ECCE84-2445-479D-94E6-B1028281EB3BQ35853542-62FECFFC-1ED0-49F7-A8B0-D482F725FBFFQ35859887-3CF4BA34-D37A-4732-9270-FEB64C58F77BQ35941208-92D9265C-0BAD-4901-844A-B836BCF93E87Q35947683-CAEF34F2-F43B-4778-8491-115FB8763B6CQ36235031-70B3399F-0EA9-41B9-AB6A-F7D7D6681BB3Q36288076-02993F3D-2354-4694-ABA5-C43DAD6B9293Q36362138-3CE1A8C6-0F48-49EC-AA1C-68C483E33392Q36426104-24052723-C1A1-44D6-B02C-7AAFE3948671Q36447542-60871263-D651-41B0-8A25-E374CC4DD0C2
P2860
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
@en
type
label
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
@en
prefLabel
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
@en
P2093
P2860
P1433
P1476
Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus
@en
P2093
J F Rodriguez
R Janeczko
P2860
P304
P407
P577
1985-11-01T00:00:00Z